Martin A Kennedy Selected Research

Martin A Kennedy Research Topics

Disease

7	Drug-Related Side Effects and Adverse Reactions 01/2018 - 01/2004
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2018 - 11/2004
4	Mood Disorders (Mood Disorder) 01/2019 - 08/2009
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 12/2015
3	Borderline Personality Disorder (Personality Disorders, Borderline) 12/2020 - 06/2006
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 01/2019
2	Mental Disorders (Mental Disorder) 12/2020 - 02/2011
2	Personality Disorders (Personality Disorder) 06/2006 - 07/2003
2	Asthma (Bronchial Asthma) 09/2005 - 03/2002
1	Avoidant Restrictive Food Intake Disorder 04/2022
1	Gastroesophageal Reflux (GERD) 01/2022
1	Heartburn (Pyrosis) 01/2022
1	Gout 12/2021
1	Substance-Related Disorders (Drug Abuse) 12/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2020
1	Myotoxicity 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Pregnancy Complications 01/2019
1	Angioedema 01/2019
1	Dystonia (Limb Dystonia) 01/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Disease Susceptibility (Diathesis) 01/2018
1	Anorexia Nervosa 06/2017
1	Obesity 01/2017
1	Chemical and Drug Induced Liver Injury 04/2016
1	Alcoholism (Alcohol Abuse) 05/2015
1	Enteritis 04/2015
1	Wounds and Injuries (Trauma) 04/2015
1	Disease Resistance 04/2015
1	Communicable Diseases (Infectious Diseases) 04/2015
1	Leukemia 04/2013

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 03/2002
4	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2019 - 10/2003
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 12/2015
3	MicronutrientsIBA 01/2020 - 01/2019
3	2-mercaptopurineIBA 11/2018 - 11/2004
3	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 06/2006
3	Azathioprine (Imuran)FDA LinkGeneric 04/2013 - 11/2004
3	Antidepressive Agents (Antidepressants)IBA 08/2009 - 12/2003
2	Biological ProductsIBA 04/2022 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2017
2	antineoplaston A10 (A 10)IBA 01/2020 - 12/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2011
2	EnzymesIBA 01/2019 - 05/2008
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 06/2010
2	Thioguanine (Tioguanine)FDA Link 11/2018 - 04/2013
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 04/2013 - 05/2008
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2011 - 01/2004
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 10/2009 - 06/2006
2	Dopamine D3 ReceptorsIBA 06/2006 - 07/2003
1	cytochrome P-450 CYP2C subfamilyIBA 01/2022
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2022
1	Cytochrome P-450 CYP2C19IBA 01/2022
1	Uric Acid (Urate)IBA 12/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Vitamin D-Binding ProteinIBA 07/2020
1	Vitamin D FDA LinkGeneric 07/2020
1	25-hydroxyvitamin DIBA 07/2020
1	hydroxide ionIBA 07/2020
1	Cholecalciferol (Vitamin D3)FDA Link 07/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	NeuroserpinIBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	BradykininIBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	LithiumIBA 01/2019
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2019
1	MineralsIBA 01/2019
1	Monoamine Oxidase (MAO)IBA 01/2019
1	NeurotensinIBA 01/2019
1	NTproCNPIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Substance PIBA 01/2019
1	VitaminsIBA 01/2019
1	SerpinsIBA 01/2019
1	Bradykinin Receptors (Bradykinin Receptor)IBA 01/2019
1	Natriuretic PeptidesIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 11/2018
1	GuanineIBA 11/2018
1	6-methylthiopurineIBA 11/2018
1	NucleotidesIBA 11/2018
1	Ligases (Synthetase)IBA 11/2018
1	HLA-B Antigens (HLA-B)IBA 01/2018
1	A-Form DNA (A-DNA)IBA 06/2017
1	Floxacillin (Flucloxacillin)IBA 04/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2015
1	Therapeutic UsesIBA 12/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2015
1	Naltrexone (ReVia)FDA LinkGeneric 05/2015
1	Citalopram FDA LinkGeneric 05/2015
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 04/2015

Therapy/Procedure

3	Therapeutics 12/2021 - 05/2008
1	Precision Medicine 12/2020
1	Critical Care (Surgical Intensive Care) 01/2019